Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 45,000 | |||
5 mg | 在庫あり | ¥ 111,000 | |||
10 mg | 在庫あり | ¥ 159,000 | |||
25 mg | 在庫あり | ¥ 248,000 | |||
50 mg | 在庫あり | ¥ 342,000 |
説明 | ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease. |
In vitro | ENT-C225 demonstrates superior physicochemical properties, higher potency in activating TrkBR, and promising neuroprotective characteristics. Treatment with ENT-C225 at a concentration of 1 µM for 20 minutes significantly promotes phosphorylation of the TrkB receptor in NIH-3T3 TrkB cells and primary astrocytes[1]. |
分子量 | 488.62 |
分子式 | C26H40N4O5 |
CAS No. | 2919962-53-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ENT-C225 2919962-53-9 Tyrosine Kinase/Adaptors Trk receptor Inhibitor inhibitor inhibit